The total return over the past 12 months is +19.56% vs. +16.94% for the S&P 500. So far it's up +25.18% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +19.56% | +44.90% | (27.50%) | N/A | N/A | N/A |
| Total Return CAGR | +19.56% | +44.90% | (27.50%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Solid Biosciences Inc. (SLDB)
| Year | Start price | End price | SLDB Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.64 | $7.06 | +25.18% | +14.51% | +10.67% |
| 2025 | $4.00 | $5.64 | +41.00% | +17.72% | +23.28% |
| 2024 | $6.14 | $4.00 | (34.85%) | +24.89% | (59.74%) |
| 2023 | $5.38 | $6.14 | +14.13% | +26.19% | (12.06%) |
| 2022 | $26.25 | $5.38 | (79.50%) | (18.17%) | (61.33%) |
| 2021 | $113.70 | $26.25 | (76.91%) | +28.74% | (105.65%) |
| 2020 | $66.75 | $113.70 | +70.34% | +18.37% | +51.97% |
| 2019 | $402.00 | $66.75 | (83.40%) | +31.22% | (114.62%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
